6-hydroxymethyl-4-methoxy-2-phenylpyrimidine | 99141-44-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6-hydroxymethyl-4-methoxy-2-phenylpyrimidine
• 英文别名: (6-Methoxy-2-phenylpyrimidin-4-yl)methanol
• CAS: 99141-44-3
• 化学式: C₁₂H₁₂N₂O₂
• 分子量: 216.239
• InChiKey: WOACRVZXKAYTAC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  55.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (Z)-5-ethoxycarbonylmethylene-3-phenyl-5,6-dihydro-4H-1,2,4-oxadiazine 在 Ni-Ra 氢气 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 25.0 ℃ 、303.98 kPa 条件下， 反应 24.0h， 生成 6-hydroxymethyl-4-methoxy-2-phenylpyrimidine
  参考文献：
  名称：

  Tabei, Katsumi; Kawashima, Etsuko; Takada, Toyozo, Heterocycles, 1982, vol. 19, # 11, p. 2061 - 2066

  摘要：

  DOI：

文献信息

• [EN] NEW THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX DÉRIVÉS DE THIÉNOPYRIMIDINE, PROCÉDÉ POUR LEUR PRÉPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：SERVIER LAB

  公开号：WO2015097123A1

  公开（公告）日：2015-07-02

  Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description.

  式（I）的化合物：其中R1、R2、R3、R4、R5、R6、R7、R12、X、A和n的定义如描述中所述。
• THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：LES LABORATOIRES SERVIER

  公开号：US20150175623A1

  公开（公告）日：2015-06-25

  Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 12 , X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

  式(I)的化合物，其中R1、R2、R3、R4、R5、R6、R7、R12、X、A和n的定义如说明中所述。含有该化合物的药物可用于治疗涉及凋亡缺陷的病理学，如癌症、自身免疫性疾病和免疫系统疾病。
• Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
  申请人：LES LABORATOIRES SERVIER

  公开号：US10278972B2

  公开（公告）日：2019-05-07

  Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

  式(I)化合物： 其中 R1、R2、R3、R4、R5、R6、R7、R12、X、A 和 n 如说明中所定义。 含有相同成分的药物产品，可用于治疗涉及细胞凋亡缺陷的病症，如癌症、自身免疫性疾病和免疫系统疾病。
• Tabei, Katsumi; Kawashima, Etsuko; Takada, Toyozo, Heterocycles, 1982, vol. 19, # 11, p. 2061 - 2066
  作者：Tabei, Katsumi、Kawashima, Etsuko、Takada, Toyozo、Kato, Tetsuzo

  DOI：——

  日期：——
• New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
  申请人：Les Laboratoires Servier

  公开号：EP2886545B1

  公开（公告）日：2016-06-29